Thomas Insel, the Director of the National Institute on Mental Health comments on a recent study of the long term effects of antipsychotic maintenance for schizophrenics. The study looked at patients who discontinued antipsychotics compared to those who were maintained on antipsychotics.
…by seven years, the discontinuation group had achieved twice the functional recovery rate: 40.4 percent vs. only 17.6 percent among the medication maintenance group.
…antipsychotic medication, which seemed so important in the early phase of psychosis, appeared to worsen prospects for recovery over the long-term. … At least for these patients, tapering off medication early seemed to be associated with better long-term outcomes.
…It appears that what we currently call “schizophrenia” may comprise disorders with quite different trajectories. For some people, remaining on medication long-term might impede a full return to wellness.
Mad in America reports that this information has been around for years and the establishment has willfully ignored it. He adds that there’s also a better way to respond to psychosis.
The Open Dialogue therapy protocol delays the use of antipsychotics in first-episode patients, instead utilizing psychosocial support and selective use of anxiety-reducing benzodiazepines (e.g. Ativan, Klonopin,Valium) with the hope that patients can “chill out,” and get through their first crisis without ever going on antipsychotic medications. And if patients need to go on antipsychotics, the Open Dialogue protocol allows for them to subsequently try to taper from the drugs.
The results? “With this selective use of antipsychotics,” Whitaker reports, “Open Dialogue has produced the best long-term outcomes in the developed world. At the end of five years, 67% of their first-episode patients have never been exposed to antipsychotics, and only 20% are maintained regularly on the drugs. With this drug protocol, 80% of first episode patients do fairly well over the long-term without antipsychotics.”
This begs a critical question. If antipsychotics are impede the recovery of many schizophrenics, what do they do to the millions of non-psychotic adults and children that are prescribed them?
One other observation. This notion of “functional recovery rate” sounds a lot like quality of life. Interesting that this is the kind of measurement exposed this pharmacological treatment as harmful for many patients and some prominent advocates of a pharmacological treatments have dismissed quality of life as an outcome measurement.
UPDATE: This is precisely why so many of us have been so concerned about mergers between mental health and addiction treatment systems. Many of these mergers are really the mental health system taking over addiction treatment systems.
- Amazing Victory for Mental Health Activists: NIMH Director Accepts Once Seen Radical Ideas (madinamerica.com)
- “Should We Stop Using Antipsychotic Medication?” (madinamerica.com)
- Blog Post ” Antipsychotics: Taking the Long View (nimh.nih.gov)
- Why Drugging All Schizophrenics For Life Is Not the Answer (rinf.com)
- The tide is turning…yes, psychiatry must face reality (heilablog.com)